ArticleAmerican journal of preventive cardiology2025
Interleukin-6 is associated with high-risk plaque on coronary computed tomography angiography in asymptomatic women.
Article in American journal of preventive cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors.
Funding
Abstract
Background: Coronary high-risk plaque (HRP) is associated with inflammation and adverse outcomes in symptomatic individuals with coronary artery disease (CAD), yet determinants of HRP in asymptomatic individuals without known CAD remain ambiguous. Objectives: We examined the association between interleukin 6 (IL-6) levels and HRP in asymptomatic women without known CAD and hypothesized higher IL-6 levels will be associated with HRP. Methods: We measured serum IL-6 levels and performed Coronary Computed Tomography Angiography (CCTA) in 77 women without known CAD enrolled in the Atlanta Women's Interagency HIV Study (median age 54, 92.2% Black, 67.5% living with HIV). Those with spotty calcification, napkin ring sign, low attenuation, or positive remodeling coronary plaque features on visual or semi-automated analyses were categorized as having HRP. We used logistic regression models adjusted for clinical and sociodemographic risk factors or the pooled cohort equation (PCE). Results: The median PCE score was 5.4%, the median IL-6 level was 2.18 [1.33, 3.59] pg/mL, 51.9% had coronary plaque and 38.9% had HRP on CCTA. Women with IL-6 concentrations in the top quartile (IL-6 > 3.59 pg/mL) were more likely to have HRP than those in lower quartiles (63.2%¦vs. 31%, p=0.01). IL-6 levels were associated with HRP prevalence, independent of cardiovascular risk factors (OR [95% CI]: 1.43 [1.12, 1.92], p=0.008) or PCE score (OR: 1.36 [1.09, 1.77], p=0.01) or HIV status. Conclusion: In asymptomatic, predominately Black women, IL-6 mediated inflammation is associated with a greater likelihood of the presence of HRP.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.